INTRODUCTION
Somatostatin (SS) and glycine are two inhibitory neurotransmitters in the mammalian central nervous system (CNS) which have been implicated in the function of sensory, motor, and nociceptive pathways (Epelbaum, 1986; . Until recently, glycine was generally not considered to play a significant role in neurotransmission above the level of the mammalian brainstem. Several reports, however, have suggested that glycine can affect neuronal activity in higher brain regions (Raiteri et al., 1990; Schmidt and Taylor, 1990; Ito and Cherubini, 1991; Shirasaki et al., 1991) . Immunocytochemical studies have shown that glycine-immunore-(IBMX), ATP, GTP, Gpp [NH] p, creatine kinase, and creatine phosphate were all supplied by Sigma Quimica (Madrid, Spain). The rabbit antibody used in the radioimmunoassay technique was purchased from the Radiochemical Centre (Amersham, U.K.). This antiserum was raised in rabbits against SS-14 conjugated to BSA and is specific for SS, but since SS-14 constitutes the C-terminal portions of both SS-25 and SS-28, the antiserum does not distinguish between these three forms. Cross-reactivity with other peptides was less than 0.5%. Crossreaction with several SS analogues demonstrated that neither the N-terminal glycine nor the C-terminal cysteine residue is required for antibody binding, suggesting that the antigen site is directed toward the central part of the molecule containing the tryptophan residue. The binding of SS-14 to this antibody does not depend on an intact disulfide bond in the molecule as breaking of the disulfide bond by reaction with 0.1 % mercaptoethanol (boiling water bath, 5 min) did not change the immunoreactivity of the peptide.
Experimental Animals
The animals used in this study were 30 Wistar rats weighing between 200 and 250 g. Rats were maintained on a 12 hr light/dark cycle (0700-1900) and allowed free access to food. Glycine was dissolved in 0.9% NaCl and administered intracerebroventricularly (i.c.v.) in a volume of 10 pl according to the method described by Noble et al. (1967) at a dose of 16 or 160 nmol of free base, as previously described (Danysz et al., 1989) . Strychnine (80 pg free base/100 g body weight) was dissolved in saline and administered intravenously via the jugular vein in a volume of 100 pU100 g body weight (Brown and Vale, 1975 ) 5 min before glycine administration. In all experiments, control animals received equivalent volumes of the corresponding vehicle. All rats were sacrificed by decapitation 15 min after the last drug injection. The brain was rapidly removed, and the frontoparietal cortex and hippocampus were dissected over ice.
Tissue Extraction and SS Radioimmunoassay
For SSLI measurements, the frontoparietal cortex and hippocampus were rapidly homogenized in 1 m12 M acetic acid using a Brinkman polytron (setting 5 , 30 sec). The extracts were boiled for 5 min in a water bath, chilled in ice, and aliquots (100 p1) were removed for protein determination (Patel and Reichlin, 1978) . The homogenates were subsequently centrifuged at 15,OOOg for 15 min at 4"C, and the supernatant was neutralized with 2 M NaOH. The extracts were then stored at -70°C until assay. The SSLI content was determined in tissue extracts by a modified radioimmunoassay method (Patel and Reichlin, 1978) , with a sensitivity limit of 10 pg/ml. Incubation tubes prepared in duplicate contained 1OO-pJ active fibers (Van den Pol and Gorcs, 1988) are present in the various brain regions known to contain SS-positive nerve terminals (Kohler and Chan-Palay, 1982; . Furthermore, a dense localization of SS receptors has been detected in the rat cerebral cortex and hippocampus (Srikant and Patel, 1981; Epelbaum et al., 1982; Czernik and Petrack, 1983; Reubi and Maurer, 1985) , two brain regions which have been demonstrated to contain inhibitory glycine receptors (Van den Pol and Gorcs, 1988; Malosio et al., 1991; Naas et al., 1991; Becker et al., 1993; Siebler et al., 1993) . Colocalization of SS and glycine has been characterized in amacrine cells of the retina (Smiley and Basinger, 1989) . In addition, both glycine and SS Vezzani et al., 1991) have been shown to possess anticonvulsant properties. In view of all this, it is reasonable to consider a reciprocal functional link between the glycinergic and somatostatinergic systems. To date, there is no report concerning the influence of glycinergic neurotransmission on SS binding or on the ability of SS to inhibit adenylyl cyclase (AC) activity in the brain. The present study was thus undertaken in order to analyze the action of glycine on specific SS receptor binding and SS-like immunoreactivity (SSLI) content in the rat frontoparietal cortex and hippocampus. Since SS modulation of neural function involves the inhibition of AC activity through activation of SS receptors coupled via GTP-binding "G" proteins to the enzyme (Schettini et al., 1989; Law et al., 1991) , the density of the SS receptor binding sites was compared with SS-mediated inhibition of AC activity in hippocampal membranes from control, glycine-, and strychnine plus glycinetreated rats. In addition, we have measured the overall catalytic activity of the enzyme using forskolin (FK), an agent which potently stimulates the catalytic subunit of AC (Schettini et al., 1989) . Furthermore, by using the stable GTP analogue 5 '-guanylylimidodiphosphate, [Gpp(NH)p] , we determined the functional activity of the Gi proteins in the control, glycine, and glycine plus strychnine groups. In view of the rapid onset of glycine action in the CNS , rats from all experimental groups were sacrificed 15 min after the last drug injection.
MATERIALS AND METHODS Chemicals
Synthetic Tyr"-SS and SS-14 were purchased from Universal Biologicals Ltd (Cambridge, U.K.); carrier-free Na'251 (IMS 30, 100 mCi/ml) and rabbit antibody were purchased from the Radiochemical Centre (Amersham, U.K.); glycine, strychnine sulfate, bacitracin, bovine serum albumin (BSA), FK, phenylmethylsulfonyl fluoride (PMSF), 3-isobutyl-1 -methylxanthine samples of unknown or standard solutions of 0-500 pg cyclic SS tetradecapeptide diluted in phosphate buffer (0.05 M, pH 7.2 containing 0.3% BSA, 0.01 M EDTA), 200 pl of appropriately diluted anti-SS serum, 100 pl of freshly prepared 1251-Tyr' '-SS diluted in buffer to give 6,000 cprdassay tube (equivalent to 5-10 pg), and enough buffer to give a final volume of 0.8 ml. All reagents, as well as the assay tubes, were kept chilled in ice before their incubation for 48 hr at 4°C. Separation of bound and free hormone was accomplished by the addition of 1 ml dextran-coated charcoal (dextran T-70: 0.2% w/v, Pharmacia, Uppsala, Sweden; charcoal Norit A: 2% w/v, Serva, Feinbiochemica, Heidelberg, Germany). Serial dilution curves for each brain area were parallel to the standard curve. The intra-and interassay coefficients of variation were 6.2 and 8.6%, respectively.
Binding Assay
Tyr' '-SS was radioiodinated by Chloramine-T iodination according to the method of Greenwood (Greenwood et al., 1963) . The tracer was purified in a Sephadex G-25 fine column (1 X 100 cm) equilibrated with 0.1 M acetic acid containing BSA 0.1 % (w/v). The specific activity of the purified labeled peptide was about 600 Ci/g.
Hippocampal and frontoparietal cortex membranes were prepared as previously described by Reubi et al. (198 1) . Protein concentration was assayed by the method of Lowry (Lowry et al., 1951) , with BSA as a standard. Specific SS binding was measured according to the modified method of Czernik and Petrack (1983) . Briefly, the membranes (0.15 mg protein/ml) were incubated in 250 pl of a medium containing 50 mM Tris-HC1 buffer (pH 7 3 , 5 mM MgCl,, 0.2% (w/v) BSA, and 0.1 mg/ml bacitracin with 250 pM '251-Tyr"-SS either in the absence or presence of 0.01-10 nM unlabeled SS. After a 60-min incubation at 30"C, bound and free ligand were separated by centrifugation at 11,OOOg for 2 min, and the radioactivity in the resultant pellet was measured. Nonspecific binding was obtained from the amount of radioactivity bound in the presence of M SS and represented about 20% of the binding observed in the absence of unlabeled peptide. This non-specific component was subtracted from the total bound radioactivity in order to obtain the corresponding specific binding.
Evaluation of Radiolabeled Peptide Degradation
The inactivation of '251-Tyr'1-SS in the incubation medium after exposure to membranes was studied by measuring the ability of preincubated peptide to rebind to fresh membranes. Briefly, '251-Tyr"-SS (250 pM) was incubated with membranes from rat hippocampus and frontoparietal cortex (0.15 mg proteidml) for 60 min at 30°C. After this preincubation, aliquots of the medium were added to fresh membranes and incubated for an additional 60 min at 30°C. The fraction of the added radiolabeled peptide which was specifically bound during the second incubation was measured and expressed as a percentage of the binding that had been obtained in control experiments performed in the absence of membranes during the preincubation period.
Adenylyl Cyclase Assay
AC activity was measured as previously reported (Houslay et al., 1976) with minor modifications. Briefly, hippocampal and frontoparietal cortex membranes (0.06 mg/ml) were incubated with 1.5 mM ATP, 5 mM MgSO,, 10 pM GTP, an ATP-regenerating system (7.5 mg/ml creatin phosphate and 1 mg/ml creatine kinase), 1 mM IBMX, 0.1 mM PMSF, 1 mg/ml bacitracin, 1 mM EDTA, and test substances (lop4 M SS or lop5 M FK) in 0.1 ml of 0.025 M triethanolamine/HCl buffer (pH 7.4). After a 15-min incubation at 30"C, the reaction was stopped by heating the mixture for 3 min. After cooling, 0.2 ml of an alumina slurry (0.75 g/ml in triethanolamine/HCl buffer, pH 7.4) was added, and the suspension was centrifuged. The supernatant was taken for assay of cyclic AMP (CAMP) by the method of Gilman (1970) . The SS concentration used was that necessary to achieve inhibition of rat (Schettini et al., 1989) and human (Bergstrom et al., 1991) brain AC activity. FK was used at a concentration that could effectively stimulate the catalytic subunit of rat AC (Schettini et al., 1989) .
Data Analysis
The computer program LIGAND (Munson and Rodbard, 1980) was used to analyze the binding data. The use of this program enabled models of receptors that best fit the given sets of data to be selected. The same program was also used to present the data in the form of Scatchard plots and to compute values for receptor affinity (Kd) and density (BmJ that best fit the sets of binding data for each rat. Statistical comparisons of all the data were carried out with one-way analysis of variance (ANOVA) and the Student Newman-Keuls test. Means among groups were considered significantly different when the P value was less than .05. Each individual experiment was performed in duplicate.
RESULTS
Glycine administration at a dose of 16 or 160 nmol increased the specific binding of SS to rat hippocampal membranes 15 min after its i.c.v. injection as compared to control conditions (Table I ; Fig. 1 ). When comparing the corresponding curves of 1251-Tyr' '-SS displacement by increasing concentrations of the unlabeled neuropep- tide, the binding data were significantly higher in the glycine-treated rats throughout the whole range studied (Fig. 1, left panel) . Scatchard plots of the stoichiometric binding data were linear and essentially parallel (Fig. 1,  right panel) . Interpretation of these data with the LIGAND computer program resulted in the best fit for a model with one type of SS receptor. Hippocampal membranes from glycine-treated rats exhibited a significant increase in the maximum SS-binding capacity at both doses studied (Table I ; Fig. 1 ). The corresponding K, values, however, remained unchanged after glycine administration. No changes in either the number or affinity of SS receptors were detected in frontoparietal cortex membranes of rats treated with 16 or 160 nmol of glycine ( Table I) .
To assess whether glycine exerts a direct action on SS receptors, glycine (lop5 M) was included in the incubation medium at the time of the binding assay with hippocampal membranes from normal rats. The addition of glycine had no effect on the SS receptors from this brain area (data not shown).
Hippocampal or frontoparietal cortex membranes from each experimental group showed a similar peptide degradation capacity, and the values varied by no more than 10% among the experimental groups.
Since the rise in the number of SS receptors was observed only in the hippocampus and the effect was greater in rats treated with 160 nmol (33.2% increase) than in those treated with 16 nmol (17.6% increase), the functional coupling of SS receptors to the AC system was studied in hippocampal membranes from control rats and rats treated with 160 nmol of glycine. The effect of SS on basal and FK-stimulated AC activity was markedly increased in hippocampal membranes from glycine (160 nmo1)-treated rats as compared to control animals (Table 11 ; Fig. 2 ). Basal AC activity was significantly decreased in rats treated with 160 nmol of glycine as (Table 11 ; Fig. 2 ). To test if the observed changes were related to modifications in the expression of AC, we measured the response of the enzyme to the diterpene FK, which is assumed to act directly upon the catalytic subunit. No significant differences were detected for FK-stimulated AC activity between the control and glycine-treated groups (Table 11) .
Further experiments explored the effect of glycine on the functional activity of Gi proteins in rat hippocampal membranes by determining the ability of Gpp(NH)p to inhibit FK (3 X lop6 M)-stimulated AC activity, an effect that has been used by other investigators as a measure of G, function in membranes prepared from different tissues (Young et al., 198 1) . Hippocampal membranes derived from control rats yielded a characteristic biphasic response curve, as shown in Figure 3 , which is assumed to be the result of G, protein activation at lower concentrations of Gpp(NH)p followed by G, protein activation at higher concentrations. Gpp(NH)p decreased FK-stimulated AC activity with a maximum inhibition observed at M in control animals. The inhibitory effect of Gpp(NH)p on FK-stimulated AC activity was markedly increased in hippocampal membranes from glycinetreated rats (Fig. 3) .
Pretreatment with strychnine, a selective and competitive antagonist of glycine receptors, prevented the changes in SS receptors (Table I; Fig. 4 ), SS-mediated inhibition of AC activity (Table II) , and Gi function (Fig.  3 ) induced by glycine in hippocampal membranes.
SSLI content in the frontoparietal cortex or hippocampus was unaffected by glycine administration or by pretreatment with strychnine (Table 111) .
DISCUSSION
This study demonstrates for the first time that the i.c.v. administration of glycine induces an increase in the number of SS receptors, an increase in the functional activity of G, proteins, and a greater SS-mediated inhibition of AC activity, with no changes in SSLI content, in the hippocampus but not the frontoparietal cortex of the rat. The present data suggest that hippocampal SS receptors may be modulated by glycine in vivo. This regulation may reflect a positive feedback mechanism further enhancing the modulatory effects of glycine on SS neurotransmission.
The SSLI content and the equilibrium parameters of the SS receptors in the hippocampus and frontoparietal cortex of control rats were similar to those previously reported by others (Epelbaum et al., 1982; Pitkanen et al., 1986) . Although the Scatchard plots of the stoichiometric data appear to be linear, this is no proof for receptor homogeneity. Indeed, it has been demonstrated for many years that SS binding in rat brain is heterogeneous (Reubi, 1984) . It has recently been demonstrated that there are five cloned SS receptors which appear to be expressed in the brain (Bruno et al., 1993) and which all have similar high affinity for SS (Bell and Reisine, A relatively high concentration of SS ( lop4 M) was required to produce inhibition of AC activity. This same SS concentration was used by Schettini et al. (1989) and Bergstrom et al. (1991) in their studies on SS-mediated inhibition of AC activity in the rat and human brain. This concentration is three log units higher than that necessary to displace '251-Tyr"-SS binding. A possible explanation for this discrepancy may lie in the observation that G proteins can modulate the affinity of SS receptors and/or the coupling to the effector system (AC among others). In this respect, Enjalbert et al. (1983) demonstrated that the mobilization of the G protein by GTP reduces the SS receptor affinity for the neuropeptide in cerebral cortical cells. Indeed, in the presence of GTP necessary to couple the SS receptor to the AC catalytic subunit, the SS receptor may shift from an apparent high-affinity state (observed in binding studies) to an apparent low-affinity state (observed in AC studies).
Although it is early to speculate on the molecular mechanism of the glycine-mediated increase in the number of SS receptors, the glycine receptors seem to mediate the action of this neurotransmitter since the changes induced by glycine on the SS receptodeffector system were effectively antagonized by pretreatment with the alkaloid strychnine. In addition, the increase in tracer binding was not due to a direct effect of glycine on SS receptors since no change in '251-Tyr'L-SS binding was detected following incubation of fresh hippocampal membranes with glycine. The interaction of glycine with its receptor causes neuronal hyperpolarization by gating an ion channel selective for chloride, an effect which is specifically blocked by strychnine (Curtis et al., 1968) .
It is possible that hyperpolarization mediated by chloride channels coupled to glycine receptors is an important factor in the action of glycine on the SS receptorieffector system. At present, there is evidence supporting the hypothesis that changes in membrane polarization may induce modifications in the number of receptors present in that membrane (Liles and Nathanson, 1987) . The question arises as to whether the effect of glycine on the '251-Tyr"-SS receptors is a result of a direct interaction of the glycinergic system on the somatostatinergic system or if it is mediated through interactions between SS and other neurotransmitters whose release can be modified by glycine. Several reports of strychnine-sensitive, glycine-induced norepinephrine and acetylcholine release from rat hippocampus have appeared (Raiteri et al., 1990; Schmidt and Taylor, 1990) . The site at which glycine acts to produce norepinephrine or acetylcholine release in the hippocampus is pharmacologically similar to the glycine receptor of the mammalian spinal cord and is not related to the glycine site associated with the NMDA subtype of glutamate receptors (Schmidt and Taylor, 1990) . Since the observed changes in SS binding are detected in an area rich in noradrenergic and cholinergic innervation (Delfs et al., 1984; Milner and Bacon, 1989) , it can be speculated that the acute effects of glycine treatment on SS receptor binding in the hippocampus may be a result of SS-noradrenaline and/or SS-acetylcholine interactions. In this regard, our group of investigation has previously demonstrated that both the al-adrenergic and the cholinergic nicotinic systems induce an increase in the number of SS receptors in the rat hippocampus (Barrios et al., 1990; L6pez-Safiudo and Arilla, 1994) .
The lack of effect of glycine on SS receptors in the frontoparietal cortex indicates the existence of regional differences in the interactions between glycine and SS. This difference could possibly be due to regional differences in the density of the glycine receptors. Variants of the a subunit which forms part of the glycine receptoral, a2, and &,-have recently been identified by cDNA cloning in rodent and human CNS (Kuhse et al., 1990) .
In situ hybridization studies have demonstrated regional differences in the expression of these different glycine receptor a subunits (Malosio et al., 1991) . The expression of a2 mRNA was detected in the dentate gyms and CA2, CA3, and CA4 regions of the rat hippocampus at moderate levels, whereas in the cerebral cortex, a,-positive cells appeared to be largely confined to the deeper layer of lamina VI. Furthermore, expression of a3 mRNA was consistently observed throughout the hippocampal formation, whereas only the infralimbic cortex contained a3 transcripts. As the a3 subunit forms strychnine-sensitive chloride channels upon expression in Xenopus oocytes, it has been considered a ligand-binding subunit of a strychnine-sensitive adult-type glycine receptor (Kuhse et al., 1990) .
Since cerebral SS receptors are coupled via inhibitory Gi proteins to different cellular effector systems (Law et al., 1991) , an analysis of Gi protein function was carried out by activating Gi proteins directly with low concentrations of the stable GTP analogue Gpp(NH)p. Glycine administration at a dose of 160 nmol induced an increase in functional Gi activity as compared to control values. G proteins contain three subunits (a, p, y) which undergo dissociation when activated (Gilman, 1987) . Several studies have demonstrated that hormone-sensitive G proteins are regulated by C1-ions (Sternweis et al., 1986; Higashijima, 1992) . C1-ions have been shown to potentiate dissociation of the Gi protein into a and Py subunits (Sternweis et al., 1986) . Since glycine activates a selective C1-ion channel through interaction with its receptors, such a regulatory effect of C1-ions may explain the increase in Gi protein functionality observed in the present study. Go proteins have also been shown to be regulated by C1- (Higashijima et al., 1987) . Since SS receptors are coupled to the inhibition of Ca2+ channels apparently through interaction with a G, protein and SS binding has been demonstrated to be dependent on the extracellular Ca2+ concentration (Susini et al., 1985) , it is tempting to speculate that the increase of SS receptors in glycine-treated rats may be related to changes in CaZ4 concentration resulting from the activation of Go.
Glycine administration decreased basal AC activity as compared to control values. The increase in Gi function induced by glycine administration may be responsible for this effect. The FK-stimulated AC activity, however, was similar in hippocampal membranes of control and glycine-treated rats, indicating that the catalytic subunit of AC is intact. The capacity of lop4 M SS to inhibit basal and FK-stimulated AC activity is significantly greater in rats treated with 160 nmol of glycine than in the control animals. This increased sensitivity of AC to SS caused by glycine administration may be a consequence of the rise in the number of SS receptors observed. Alternatively, the increase in Gi functional activity may participate in the increased SS-mediated inhibition of the enzyme, although it is highly probable that a combination of both factors is involved.
The functional significance of the present results is unknown. Immunohistochemically , glycine receptors have been preferentially localized to the apical dendrites of pyramidal neurons in layers I11 and V of the hippocampus ( Van den Pol and Gorcs, 1988) . In this same brain area, immunohistochemical studies have revealed many SS-containing interneurons (Kohler and Chan-Palay, 1982; Joels et al., 1990 ) and a profuse network of intrinsic and extrinsic SS-containing fibers which appear
